Record Display for the EPA National Library Catalog

RECORD NUMBER: 15 OF 22

OLS Field Name OLS Field Data
Main Title In vitro/In vivo Effects of Ethane Dimethanesulfonate on Leydig Cells of Adult Rats.
Author Klinefelter, G. R. ; Laskey, J. W. ; Roberts, N. L. ;
CORP Author NSI Technology Services Corp., Research Triangle Park, NC.;Health Effects Research Lab., Research Triangle Park, NC. Reproductive Toxicology Branch.
Publisher c1991
Year Published 1991
Report Number EPA-68-02-4450; EPA/600/J-91/049;
Stock Number PB91-191569
Additional Subjects Toxicology ; Leydig cells ; Rats ; Testosterone ; Biosynthesis ; Cyclic adenosine monophosphate ; Protein kinases ; Cholesterol ; In vitro analysis ; In vivo analysis ; Electron microscopy ; Enzyme activation ; Chorionic gonadotropins ; Reprints ; Ethane demethanesulfonate
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
NTIS  PB91-191569 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. 09/04/1991
Collation 14p
Abstract
Ethane dimethanesulphonate (EDS) is well-recognized as a Leydig cell toxicant. Although this compound has been studied extensively to date, certain toxicological criteria have not been met. For instance, the dose-responsiveness of Leydig cells to EDS, both in vitro and in vivo, is not well established. In addition, the data regarding the cellular site of action of EDS during Leydig cell toxicity and the status of Leydig cell viability during the affected period remains controversial. The study used both highly purified (98 %) and interstitial (14 %) Leydig cell preparations to determine the in vitro EC50 (370 micro M) and in vivio (sub 50) (60 mg/kg) for hCG-stimulated testosterone (T) production, respectively. Leydig cells were recovered in approximately equal number following all in vivo and in vitro EDS exposures. Test results indicate that when Leydig cells are exposed to EDS either in vitro or in vivo, the biosynthesis of T is compromised between the production of cyclic adenosine monophosphate (CAMP) activation of protein kinase and the cholesterol side chain cleavage enzyme.